OMECARDIO trial: a randomized, double-blind, placebo-controlled study on the impact of omega-3 on inflammageing biomarkers and vascular stiffness in hypertensive and dyslipidemic patients
Features of changes in the blood levels of pro-inflammatory interleukin-17A in patients with arterial hypertension, which occurs with a background of abdominal obesity